Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Cardiovascular Drugs and Therapy|May 9, 2007
Pharmacogenomics of renin angiotensin system inhibitors in coronary artery diseaseJames P Tsikouris, Michael J PeetersJournal of Clinical Pharmacology|March 31, 2004
Preventing contrast nephropathy: what is the best strategy? A review of the literatureCraig D Cox, James P TsikourisPharmacotherapy|October 4, 2003
Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actionsJames P Tsikouris, Craig D CoxJournal of Cardiovascular Pharmacology|November 20, 2004
The use of angiotensin receptor blockers in the treatment of chronic heart failureBrian K Irons, James P Tsikouris, Audra A ThomasJournal of Clinical Pharmacology|November 5, 2002
Plasminogen activator inhibitor-1: physiologic role, regulation, and the influence of common pharmacologic agentsJames P Tsikouris, Jose A Suarez, Gary E MeyerrosePharmacotherapy|October 30, 2007
Fibrinolytic agents for the management of ST-segment elevation myocardial infarctionDaniel E Hilleman, James P Tsikouris, A Allen Seals, et al.Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|April 25, 2007
Evaluation of angiotensin converting enzyme (ACE)-like activity of acellular hemoglobinJan Simoni, Grace Simoni, John F Moeller, et al.Coronary Artery Disease|June 10, 2004
Exploring the effects of ACE inhibitor tissue penetration on vascular inflammation following acute myocardial infarctionJames P Tsikouris, Jose A Suarez, Jan S Simoni, et al.Pharmacotherapy|January 17, 2002
An economic analysis of amiodarone versus placebo for the prevention of atrial fibrillation after open heart surgeryPrabashni Reddy, Alisha B Dunn, C Michael White, et al.The American Journal of Cardiology|September 3, 2004
Comparison of effects of quinapril versus enalapril on vasoactive substances following acute myocardial infarctionJames P Tsikouris, Jan Simoni, Jose A Suarez, et al.Pageof 2